Introduction {#S0001}
============

Brucellosis is the most common zoonotic bacterial infection worldwide with endemic patterns in some countries such as Iran, Turkey, Kuwait, Saudi Arabia, and Peru (most commonly seen in the Middle East, Central, and South America).[@CIT0001]--[@CIT0003] The disease is caused by *Brucella* species; a small, gram-negative, non-motile, non-spore-forming, intracellular-reproducing, aerobic coccobacilli microorganism that can survive inside macrophages due to specific survival mechanisms.[@CIT0001],[@CIT0004] Dairy products contaminated with *Brucella melitensis* (mostly sheep and goat milk) seems to be the first main source of human brucellosis worldwide.[@CIT0005] Brucellosis is a systemic disease and systemic infection may involve any organ or system of the body such as reticuloendothelial system (spleen, liver, bone marrow, and lymph nodes), gastrointestinal, central nervous system, cardiovascular, musculoskeletal, genitourinary, and integumentary systems.[@CIT0006],[@CIT0007] Cutaneous involvement has also been described for brucellosis, but it is uncommon and unspecific.[@CIT0008] Manifestations of cutaneous involvement have been described mostly as disseminated papulonodular eruption, erythema nodosum-like lesions, diffuse maculopapular rash, maculopapular eruptions, psoriasiform lesions, palmar erythema, malar eruption, and palmar eczema.[@CIT0009]--[@CIT0011] In summary, we can divide skin lesions associated with brucellosis into most frequent, such as papulonodular lesions, erythema nodosum-like lesions, maculopapular eruptions, petechiae, purpura, and contact urticaria, and less frequent, such as vasculitic lesions, subcutaneous abscesses, chronic ulcerations, liquefactive panniculitis, recurrent epidermal cysts, palmar erythema, and livedo reticularis.[@CIT0012]

Case presentation {#S0002}
=================

A 71-year old Iranian man was referred to the dermatology clinic of Ayatollah Taleghani Hospital of Urmia in September 2018. The patient had a history of visits to the neurosurgery department in August 2018 with a complaint of low back pain with non-specific clinical symptoms (tenderness without radiculopathy), and lumbosacral/spine magnetic resonance imaging (MRI) without contrast was performed. MRI reported decrement in lumbar lordosis, extensive bone marrow edema at L4 and L5 vertebral bodies, and obliteration of L4-L5 disk. The appearance was "suspicious" for infectious spondylodiscitis ([Figure 1A](#F0001){ref-type="fig"}--[C](#F0001){ref-type="fig"}). At a visit to the dermatology department (September 2018), the patient's chief complaint was patchy and vesicular plaque lesions on the anterior left thigh and the left buttock region, matching dermatomal pattern (L2-L5). Lesions appeared about 20 days before the visit and were not itchy, painful or exuding at first but gradually increased and became purulent. The patient was admitted to the dermatology ward with a diagnosis of *Herpes zoster* infection. The patient had a history of smoking (20 packs/year), hypertension for the last 4 years, and underwent a laparotomy due to perforated peptic ulcer 2 years ago. He was taking losartan 25 mg BID for hypertension. The biochemical laboratory data on admission are reported in [Table 1](#T0001){ref-type="table"}. Complete blood count revealed white blood cell count of 5,400/mL (neutrophil: 60%, lymphoid: 33%, and MXD: 7%), red blood cell count of 3.46 million/mL, hemoglobin of 9.9 gr/dL, hematocrit of 29.8%, mean corpuscular volume of 86.13 fl, and platelet count of 284,000/mL. During admission the patient was afebrile. The patient was discharged after 3 days of hospitalization with medical therapy of cephalexin capsules 500 mg QID and gabapentin. The lesions had improved relatively during hospitalization but were not completely resolved.Table 1Biochemical laboratory data from dermatology ward admissionLaboratory dataValueNormal reference rangeAspartate aminotransferase14 U/L\<37 U/LAlanine transaminase12 U/L\<41 U/LAlkaline phosphatase252 U/L80--360 U/LTotal bilirubin0.4 mg/dL0.1--1.2 mg/dLDirect bilirubin0.2 mg/dL0.1--0.3 mg/dLFasting blood sugar90 mg/dL\<92 mg/dLUrea28 mg/mL19--44 mg/mLSerum creatinine1.1 mg/dL----- Figure 1Lumbosacral spine magnetic resonance imaging. Sagittal T1W view of T12-L5 (**A**), Sagittal T2W view T12-L5 (**B**), and axial view of L3-L5 (**C**).

Forty-five days later, in October 2018, the patient was referred to the infectious clinic of Ayatollah Taleghani hospital with a major complaint of low back pain and unimproved skin lesions.

The patient's low back pain started about 3 months earlier (early August 2018), it was initially low and gradually increased. The pain was continuous, increasing with activity and decreasing with rest. There were no other symptoms such as nausea, vomiting, coughing, and shortness of breath. He had had low-grade fever for about 2 weeks and also had a history of unpasteurized cheese consumption.

At the visit to the infectious disease clinic, the patient had itchy, patchy, and vesicular plaque lesions on the anterior left thigh and the left buttock region. There was no active or passive movement limitation on examination. Nervous examinations were normal. There was no lymphadenopathy.

Considering clinical symptoms, the history of unpasteurized cheese consumption, and the MRI report ([Figure 1A](#F0001){ref-type="fig"}--[C](#F0001){ref-type="fig"}), the patient was admitted to the infectious disease ward of Ayatollah Taleghani hospital for further investigation and probable diagnosis of brucellosis spondylitis. The laboratory data on admission were reported as (biochemical laboratory data are reported in [Table 2](#T0002){ref-type="table"}) complete blood count revealed: white blood cell count of 7,600/µL (neutrophil: 65%, lymphoid: 31%, MXD: 2%, and monocytes: 2%), red blood cell count of 3.94 million/µL, hemoglobin of 11 gr/dL, hematocrit of 34%, mean corpuscular volume of 86.29 fl, and platelet count of 290,000/µL. Coombs anti-Brucella and Wright test was done and the antibody titers were 1/1,280 and 1/640 respectively.[@CIT0013],[@CIT0014] Table 2Biochemical laboratory data from infectious disease ward admissionLaboratory dataValueReference normal rangeSerum creatinine0.9 mg/dL-----Serum urea21 mg/mL19--44 mg/mLRandom blood sugar142 mg/dL\<200 mg/dLSerum K4 mEq/L3.5--5 mEq/LSerum Na140 mEq/L135--145 mEq/LCarcinoembryonic antigen1.1 ng/mLSmokers 0.4--8.5 ng/mLAlpha-fetoprotein2.7 ng/mL0.2--8.5 ng/mLErythrocyte sedimentation rate 1 hour9 mm/hour\<20 mm/hourQualitative C-reactive protein4^+^-----

By considering clinical symptoms and paraclinical assessments, the diagnosis of brucellosis was confirmed and medical therapy of gentamycin 80 mg QID, doxycycline 100 mg BID, and rifampin 300 mg BID was begun. For pain management, 100 mg of gabapentin BID was prescribed and for itching and redness, topical 0.025% fluocinolone ointment TDS.

On the second day of admission, a skin lesion biopsy was done. Two weeks after the biopsy, histopathological assessment showed parakeratosis with spongiform pustule and Munro abscess, acanthosis with elongation of rete ridges and thickening of lower portion, perivascular infiltration of lymphoid cells, and exocytosis. The final histopathological diagnosis from the pathologist was compatible with psoriasis vulgaris ([Figure 2](#F0002){ref-type="fig"}).Figure 2Histopathological view of lesion biopsy, acanthosis with elongation of rete ridges and thickening of lower portion, parakeratosis with perivascular infiltration of lymphoid cells (**A--F**).

Back pain gradually decreased during admission after medical treatment for brucella was started. On the third day of admission, subjectively; the patient's pain during walking had improved. [Figure 3](#F0003){ref-type="fig"} shows gross healing process and regression of skin lesions on admission, and at the end of first, second, and third month after beginning treatment.Figure 3(**A**) The patchy and vesicular plaque lesions with dermatomal pattern on anterior left thigh at first day of admission and treatment. (**B**) Skin lesions after 1 month of treatment. (**C**) Healed skin lesions at 2 months after treatment. (**D**) Vanished papulovesicular lesions and eftfading pigmented macula and patches at the end of third month after treatment.

Conclusion {#S0003}
==========

Brucellosis is a disease with several clinical symptoms and various organ involvement and is listed in the differential diagnosis list of many diseases. Chronic brucellosis can involve the spinal cord in the form of spondylitis and spondylodiscitis that can cause fractures and even serious neurological complications. Skin manifestations are not common in brucellosis, particularly papulonodular lesions with dermatomal patterns; as seen in this case, cutaneous involvement can mimic diseases with a dermatomal pattern of involvement such as *Herpes zoster* infection. Even on histopathological assessment, the disease could mimic pemphigus vulgaris and pemphigoid lesions. By diagnosis of brucellosis through clinical and paraclinical assessment and beginning treatment, the lesions started to heal and had vanished by 3 months after the first day of treatment. This case showed a rare condition of cutaneous involvement of brucellosis that can mimic dermatomal gross pattern and pemphigoid lesions on histopathological assessment.
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